Timing and trajectory of acute kidney injury predict mortality in alcohol-associated hepatitis: A multinational cohort study.
Abstract
BACKGROUND: Acute kidney injury (AKI) is common in alcohol-associated hepatitis (AH) and associated with poor outcomes, yet the prognostic implications of AKI timing and early renal trajectory remain unclear. METHODS: In this prospective multicenter cohort from the Global AlcHep Prospective Database, patients with AH were classified as no AKI, prevalent AKI at admission, or incident AKI during hospitalization. The primary outcome was 90-day mortality, using competing-risks regression with liver transplantation as the competing event. A 7-day landmark analysis assessed the prognostic impact of AKI trajectory among prevalent AKI patients. RESULTS: Among 581 patients, 37% had prevalent AKI, and 11% developed incident AKI. The 90-day mortality was 18.2% (11 transplantations, 1.9%). Prevalent AKI was predominantly functional (84%), while incident AKI had a higher proportion of structural injury (44%). Despite lower baseline severity [median mDF 59.8 vs. 69.3 and lower rates of ACLF grade 3 (23.4% vs. 45.3%)], incident AKI conferred mortality of similar magnitude to prevalent AKI (sHR 2.18, 95% CI 1.19-3.99 vs. sHR 1.80, 95% CI 1.02-3.16). Among 7-day survivors (N=457), prevalent AKI without progression had mortality similar to no AKI (sHR 1.27, p=0.52), while prevalent AKI with progression carried the worst prognosis (sHR 3.34, 95% CI 1.44-7.77). CONCLUSION: Both prevalent and incident AKI independently predict mortality in AH. Incident AKI confers equivalent risk despite lower disease severity and a distinct etiologic profile with higher rates of intrinsic renal injury. Early renal trajectory refines risk beyond baseline AKI status, where absence of progression approximates outcomes of those without AKI, while progressive AKI identifies the highest-risk subgroup.
// Source
Authors: Butros Fakhoury, Ali Khan, Pojsakorn Danpanichkul, Omar Albhaisi, Kriti Soni, Ximena Parraga, Francisco Javier Idalsoaga, Arun Valsan, Gowripriya Nair, Jorge Arnold, Maria Ayala-Valverde, Carolina Ramirez-Cadiz, Juan Pablo Roblero, Daniela Simian, José Antonio Velarde-Ruiz Velasco, Jacqueline Córdova, Manuel Mendizábal, Sebastián Marciano, Kristina R. Chacko, Lubomir Skladaný, Michał Kukla, Arun Jayant Sanyal, Vijay H. Shah, Patrick S. Kamath, Marco A. Arrese, Winston Dunn, Ashwani Kumar Singal, Ramon A. Bataller, Luis Antonio Díaz, Juan Pablo Arab
Institutions: University of California San Diego, Western University, Montefiore Medical Center, Jagiellonian University, Pontificia Universidad Católica de Chile, Virginia Commonwealth University, Amrita Institute of Medical Sciences and Research Centre, Hospital Clínic de Barcelona, Mayo Clinic, University of Kansas Medical Center, Hospital Civil de Guadalajara, Texas Tech University, University of Chile, University of Louisville, University of Pavol Jozef Šafárik, Texas Tech University Health Sciences Center, Hospital Italiano de Buenos Aires, London Health Sciences Centre, Hospital General Dr. Manuel Gea Gonzalez, Virginia Commonwealth University Medical Center, Slovak Medical University, Montefiore Health System, Hospital Clínico de la Universidad de Chile, Hospital Universitario Austral, Szpital Uniwersytecki w Krakowie